AMYLYX PHARMACEUTICALS INC (AMLX) Institutional Ownership and Insiders Activity
AMYLYX PHARMACEUTICALS INC (AMLX) is widely held by institutional investors, with 200 firms reporting positions valued at approximately $1.98B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Fmr Llc is the largest disclosed holder, reporting approximately $300.43M in AMLX holdings in its latest filing.
Recent insider activity includes 18 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
200
Total Reported Value
$1.98B
Largest Holder
Fmr Llc
Largest Position
$300.43M
Insider Transactions (90d)
18
Latest Filing Quarter
Q2 2026
New Institutional Positions
50
Funds Exiting Positions
20
Top Institutional Owners
View allInvestorReported Balance
- Fmr Llc$300.43M
- Blackrock, Inc.$158.53M
- Perceptive Advisors Llc$149.69M
- Tcg Crossover Management, Llc$112.14M
- Commodore Capital Lp$101.47M
AMLX News
All news- Almitas Capital Portfolio Shifts in Q2 2026: Focus on Financial Services and Healthcare
Aug 22, 2026 · valut.ai
Related AMLX Institutional Insights:
- AMLX 13F Institutional Holders
- AMLX Top Institutional Shareholders
- AMLX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- AMLX Insider Trading & SEC Form 4 Activity
- AMLX Articles
- Top Institutional Investor Stock Rankings